ZA846327B - Inclusion compound of n,n-dimethyl-2-chloro-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamide,a process for its preparation and pharmaceutical products - Google Patents

Inclusion compound of n,n-dimethyl-2-chloro-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamide,a process for its preparation and pharmaceutical products

Info

Publication number
ZA846327B
ZA846327B ZA846327A ZA846327A ZA846327B ZA 846327 B ZA846327 B ZA 846327B ZA 846327 A ZA846327 A ZA 846327A ZA 846327 A ZA846327 A ZA 846327A ZA 846327 B ZA846327 B ZA 846327B
Authority
ZA
South Africa
Prior art keywords
phenylsulfonamide
thiazolin
phenylimino
chloro
dimethyl
Prior art date
Application number
ZA846327A
Other languages
English (en)
Inventor
Heinz-Ruediger Seidel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA846327B publication Critical patent/ZA846327B/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA846327A 1983-08-16 1984-08-15 Inclusion compound of n,n-dimethyl-2-chloro-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamide,a process for its preparation and pharmaceutical products ZA846327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833329517 DE3329517A1 (de) 1983-08-16 1983-08-16 Einschlussverbindung von n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)phenylsulfonamid, verfahren zu ihrer herstellung sowie pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
ZA846327B true ZA846327B (en) 1985-03-27

Family

ID=6206641

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA846327A ZA846327B (en) 1983-08-16 1984-08-15 Inclusion compound of n,n-dimethyl-2-chloro-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamide,a process for its preparation and pharmaceutical products

Country Status (10)

Country Link
EP (1) EP0141076A1 (es)
JP (1) JPS6058969A (es)
KR (1) KR850001737A (es)
AU (1) AU3196184A (es)
DE (1) DE3329517A1 (es)
DK (1) DK392384A (es)
ES (1) ES535135A0 (es)
GR (1) GR80116B (es)
PT (1) PT79080B (es)
ZA (1) ZA846327B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPH08777B2 (ja) * 1985-04-08 1996-01-10 武田薬品工業株式会社 経口用抗菌固型組成物
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
KR100503200B1 (ko) * 2000-09-05 2005-07-25 주식회사 포스코 석탄 건조설비의 석탄 불출량 제어장치

Also Published As

Publication number Publication date
AU3196184A (en) 1985-02-21
JPS6058969A (ja) 1985-04-05
DE3329517A1 (de) 1985-02-28
EP0141076A1 (de) 1985-05-15
GR80116B (en) 1984-12-14
PT79080B (de) 1986-09-08
KR850001737A (ko) 1985-04-01
DK392384A (da) 1985-02-17
DK392384D0 (da) 1984-08-15
ES8601694A1 (es) 1985-11-16
ES535135A0 (es) 1985-11-16
PT79080A (de) 1984-09-01

Similar Documents

Publication Publication Date Title
PT85531B (en) Process for the preparation of imidazole compounds and of a pharmaceutical compositions comprising the same
EG18603A (en) A method for the preparation of pharmaceutical composition
GB2140412B (en) Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof
PT86320A (en) Process for the preparation of a herbicid and or fungicid compound containing pyrazolin-5-ona replaced by products and of novel pyrazolin-5-ona replaced derivatives
GR3002839T3 (en) Substituted thiazoles and oxazoles, medicines containing these compounds and process for their preparation
EP0082498A3 (en) Beta-lactam compounds, process for the preparation thereof and intermediate products for the preparation thereof
EP0324174A3 (en) Process for the preparation of 2-chloro-5-methylpyridine
IL81564A0 (en) Insulin derivatives,a process for their preparation,and pharmaceutical compositions containing them
ZA846327B (en) Inclusion compound of n,n-dimethyl-2-chloro-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamide,a process for its preparation and pharmaceutical products
ZA88951B (en) Benzimidazoles,a process for their preparation and pharmaceutical preparations containing these compounds
DE3479656D1 (en) Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same
EG18306A (en) A process for the preparation of pharmaceutical compounds
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
ZA836512B (en) Sulfamoylbenzophenone derivatives,a process for their preparation,their use and pharmaceutical products based on these compounds
PT85360A (en) Process for the preparation of a fungicidal composition containing n-(2-cyano-2-oxyminoacetyl)-aminonitriles and intermediate products
HUT44753A (en) Process for producing gem-dihalogen-1,8-diamino-4-azaoctane derivatives and pharmaceutical preparations comprising such compounds
DE3571978D1 (en) Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them
ZA842352B (en) Gonadoliberin derivatives containing a beta-aspartyl group,a process for the preparation thereof and pharmaceutical preparations containing them
GR860366B (en) Process for the preparation of nitrogen - containing compounds and products manufactured thereof
EP0303250A3 (en) Novel pyrazinoxide compound of nf-1616-904 and a pharmaceutical composition containing the same and a process for its preparation
HUT40092A (en) Process for preparing thiazolidine derivatives and pharmaceutical preparations containing the same
ZA818689B (en) Imidazole derivatives,a process for the preparation thereof and a pharmaceutical composition containing them
ZA843757B (en) Aminocyclic derivatives,process for preparing these compounds and pharmaceutical compositions thereof
ZA832138B (en) Pyrid-2-one derivatives, a process for their manufacture and pharmaceutical preparations containing them
DE3267376D1 (en) Quinidines, process for their preparation and their pharmaceutical application